Understand how cannabis reform is shaping the midterm elections, the impact of federal rescheduling, and what to look for when evaluating candidate policies.
Based on reporting by CNBC Make It. Research, structure, and fact-checking by Groundwork.

Cannabis reform is increasingly a political tool for both parties to capture specific voter demographics. When voting, look past rhetoric and focus on a candidate's specific legislative record regarding federal rescheduling and state-level business regulation to understand their true stance.
“The shift toward Schedule III classification represents a major pivot in federal drug policy, moving the conversation from 'prohibition versus legalization' to a more technical debate about regulation and taxation. Voters should view cannabis reform as an economic and administrative issue rather than a purely ideological one.”
Cannabis reform is a legislative process where states or the federal government adjust the legal status, taxation, or regulatory framework surrounding marijuana. As midterm elections approach, the shifting status of cannabis from a controlled substance to a regulated commodity has become a point of contention for voters and candidates alike.
While economic concerns and national security often dominate headlines, recent polling indicates that cannabis legalization maintains broad, albeit shifting, appeal across the American political spectrum. Understanding where your candidates stand on this issue requires looking beyond campaign rhetoric and examining the current federal and state legal landscape.
Cannabis reform is appearing on midterm ballots because state-level initiatives provide a direct mechanism for voters to influence drug policy where federal legislative action has stalled. Ballot initiatives in states like Massachusetts and Idaho allow citizens to bypass traditional legislative hurdles, forcing candidates to take a definitive stance on legalization.
Historically, the U.S. has maintained a fractured approach to marijuana. Since 1996, 40 states and the District of Columbia have legalized some form of medical or recreational use (Source: CNBC, 2026). Despite this widespread state-level adoption, cannabis remains a Schedule I controlled substance under the 1970 Controlled Substances Act, creating a significant legal conflict between state and federal authorities. This tension serves as a primary driver for political debate, as voters seek clarity on business regulation, criminal justice reform, and medical access.
Federal rescheduling is the administrative process of moving marijuana from Schedule I—the most restrictive category—to a lower classification, such as Schedule III, which recognizes medical utility and lower abuse potential. In April 2026, the Department of Justice took a significant step by signing an order to reschedule state-licensed medical marijuana to Schedule III, following directives to expedite the change (Source: CNBC, 2026).
Moving to Schedule III has practical implications for businesses and patients. For businesses, this reclassification may allow for standard tax deductions currently prohibited under IRS code 280E, which prevents businesses trafficking in Schedule I or II substances from deducting ordinary business expenses. For patients, it signals a shift toward federal recognition of medical marijuana as a legitimate therapeutic option, similar to substances like ketamine or testosterone-based medications.
Political parties differ on cannabis legalization through their approach to regulation and the speed at which they prioritize reform. While Democrats have historically championed legalization as a platform for social justice and personal liberty, Republicans are increasingly viewing cannabis through the lens of economic growth and voter engagement, particularly among younger demographics.
Recent data suggests that while support for legalization is high among Democrats, it has seen a slight decline among some Republican cohorts (Source: CNBC, 2026). However, political strategists note that shifting positions, such as those seen in the current administration’s push for rescheduling, are often calculated moves to appeal to a broader base of voters. Candidates who support reform often frame it as a way to reduce the burden on the criminal justice system, while those who oppose it frequently cite concerns regarding public health and safety.
When evaluating a candidate’s stance on cannabis, you should look for specific policy proposals rather than general statements of support or opposition. A candidate’s position on the issue is best understood through their voting record, their support for specific state-level ballot measures, and their willingness to address federal-state regulatory conflicts.
To make an informed decision, consider the following steps:
Economic factors influence the cannabis debate by highlighting the potential for tax revenue and job creation within the legal market. As states face budgetary pressures, the prospect of taxing a multi-billion dollar industry becomes an increasingly attractive incentive for lawmakers who might otherwise remain neutral on the issue.
While cannabis is not currently the primary focus for most voters compared to inflation or infrastructure, it is a significant secondary issue for those involved in the industry or those interested in tax reform. The 'cannabis economy' includes agricultural production, retail operations, and logistics, all of which are subject to varying degrees of state regulation. When assessing a candidate, consider how their economic platform addresses the unique hurdles faced by cannabis businesses, such as access to banking services and federal tax relief. A candidate who understands the regulatory burden on these businesses is often better equipped to handle the complexities of future legalization efforts.
Priya Nair (2026). How cannabis policy impacts your vote in the midterm elections. Groundwork. Retrieved from https://gworky.com/article/cannabis-reform-midterm-elections-impact
No, federal rescheduling to Schedule III does not automatically legalize marijuana nationwide. It acknowledges medical utility and changes how the federal government regulates the substance, but states retain the authority to set their own laws regarding recreational and medical use within their borders.
The 280E tax code currently prevents businesses dealing in Schedule I or II substances from deducting standard business expenses from their federal taxes. Rescheduling to Schedule III could potentially allow these businesses to claim these deductions, significantly impacting their profitability and operational viability.
You can determine a candidate's stance by reviewing their official campaign platform, checking their past voting record on drug reform bills, and searching for local news interviews where they address state-level ballot initiatives. Many non-partisan advocacy groups also provide candidate report cards on this issue.
Data indicates that while cannabis reform is popular, it is generally considered a secondary issue compared to primary concerns like the economy, immigration, and national security. It often functions as a 'wedge issue' used to increase voter turnout among specific demographics during midterm election cycles.
Lifestyle & Legal Systems Optimizer
Lifestyle and legal systems optimizer who hunts down consumer rights, loopholes, and total-cost-of-ownership math across travel, career, and auto decisions.
This guide underwent secondary data verification to confirm primary source integrity, calculation formulas, and regulatory compliance before publication.
Prediction markets and sports betting are facing a regulatory clash. Learn how these platforms operate and what you need to know before participating.
Learn how to use your loyalty points at boutique hotels by booking through 'soft brand' collections from major chains like Marriott, Hilton, and Hyatt.
Anthropic's revenue reached $11.5 billion in Q2 2026, a 14-fold increase. Learn what this rapid growth means for the company's potential IPO and AI market.